EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy of Microneedle Fractional Radiofrequency Combined With Topical Insulin for the Treatment of Facial Atrophic Acne Scars: A Split‐Face, Double‐Blinded, Randomized, Placebo‐Controlled Trial

Teerapong Rattananukrom iD, Kasama Tejapira, Cherrin Pomsoong iD, Yanisa Ratanapokasatit, Vasanop Vachiramon iD

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70033 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Teerapong Rattananukrom und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Acne Vulgaris, Cicatrix, Insulin, Radiofrequency Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Topical insulin (TI) has been shown to enhance wound healing by promoting re‐epithelialization and collagen synthesis. However, there have been limited studies addressing its potential use in treating acne scars.

Objectives

To assess the efficacy of combining TI with microneedle fractional radiofrequency (MFR) in the treatment of atrophic acne scars. Materials and Method A split‐face, double‐blinded, placebo‐controlled trial involved 30 participants with atrophic acne scars. Each side of the participants' face was randomly treated with a combination of MFR and TI or a placebo every 4 weeks for four consecutive sessions.

Results

Significant improvements in scar volume were observed, with statistical significance at week 12 for MFR combined with TI sides (baseline 18.22 ± 9.86 vs. 16.20 ± 8.58 mm 3 , p = 0.017) and at week 16 for MFR combined with placebo sides (baseline 18.02 ± 9.24 vs. 15.28 ± 8.21 mm 3 , p = 0.001). The TI sides exhibited a reduction of 46.77% ± 21.33% in Echelle d’ évaluation clinique des cicatrices d’ acne (ECCA) ( p ≤ 0.001), while the placebo sides showed a reduction of 46.39% ± 20.14% in ECCA ( p ≤ 0.001). There were no significant differences in melanin, and hemoglobin index between the two groups. No hypoglycemic symptoms were reported.

Conclusion

Combining topical insulin with MFR is safe and could accelerate the early acne scar improvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisCicatrixInsulinRadiofrequency TherapyHumansDouble-Blind MethodAdultFemaleMaleYoung AdultTreatment OutcomeNeedlesCombined Modality TherapyFaceAdministration, CutaneousAtrophyAdolescentSkin

Stichwörter der Autor:innen

atrophic acne scarcollagen synthesismicroneedle fractional radiofrequencytopical insulin

Substanzen

Insulin

Autor:innen und Institutionen

  • Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Teerapong Rattananukrom, Cherrin Pomsoong, Vasanop Vachiramon

Zitieren

APA

Rattananukrom, T., Tejapira, K., Pomsoong, C., Ratanapokasatit, Y., & Vachiramon, V. (2025). Efficacy of Microneedle Fractional Radiofrequency Combined With Topical Insulin for the Treatment of Facial Atrophic Acne Scars: A Split‐Face, Double‐Blinded, Randomized, Placebo‐Controlled Trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70033

Vancouver

Rattananukrom T, Tejapira K, Pomsoong C, Ratanapokasatit Y, Vachiramon V. Efficacy of Microneedle Fractional Radiofrequency Combined With Topical Insulin for the Treatment of Facial Atrophic Acne Scars: A Split‐Face, Double‐Blinded, Randomized, Placebo‐Controlled Trial. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70033

BibTeX
@article{Rattananukrom2025,
  author = {Rattananukrom, Teerapong and Tejapira, Kasama and Pomsoong, Cherrin and Ratanapokasatit, Yanisa and Vachiramon, Vasanop},
  title = {Efficacy of Microneedle Fractional Radiofrequency Combined With Topical Insulin for the Treatment of Facial Atrophic Acne Scars: A Split‐Face, Double‐Blinded, Randomized, Placebo‐Controlled Trial},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70033}
}
Kostenlos starten →